Exchange: NASDAQ Sector: Healthcare Industry: Medical Care Facilities
-14.13% $1.580
America/New_York / 28 mar 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 116.52 mill |
EPS: | -0.890 |
P/E: | -1.780 |
Earnings Date: | May 07, 2024 |
SharesOutstanding: | 73.75 mill |
Avg Daily Volume: | 0.136 mill |
RATING 2024-03-28 |
---|
B+ |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Strong Sell | |
Return On Asset: | Neutral | |
DE: | Strong Buy | |
P/E: | Sell | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -1.780 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.06x |
Company: PE -1.780 | industry: PE 28.38 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 1.399 - 1.761 ( +/- 11.46%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-29 | Havencrest Healthcare Partners, L.p. | Sell | 8 637 | Common stock |
2024-01-24 | Havencrest Healthcare Partners, L.p. | Sell | 24 915 | Common stock |
2024-01-25 | Havencrest Healthcare Partners, L.p. | Sell | 11 882 | Common stock |
2024-01-26 | Havencrest Healthcare Partners, L.p. | Sell | 6 979 | Common stock |
2024-01-19 | Havencrest Healthcare Partners, L.p. | Sell | 11 986 | Common stock |
INSIDER POWER |
---|
-55.77 |
Last 99 transactions |
Buy: 4 729 076 | Sell: 9 614 245 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $1.580 (-14.13% ) |
Volume | 0.287 mill |
Avg. Vol. | 0.136 mill |
% of Avg. Vol | 212.07 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.